SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-012689
Filing Date
2016-02-04
Accepted
2016-02-04 17:30:27
Documents
1
Period of Report
2016-02-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4047
  Complete submission text file 0000899243-16-012689.txt   5394
Mailing Address 3005 FIRST AVENUE SEATTLE WA 98121
Business Address
Frohlich Mark W (Reporting) CIK: 0001420482 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36781 | Film No.: 161389490

Mailing Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109
Business Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109 2066960703
Juno Therapeutics, Inc. (Issuer) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)